Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, August 11, 2026

Snapshot: Aug 11, 2026 · 6:00 PM 100 stocks analyzed

Flat Day

Tue, Aug 11, 2026 Divergent High

Extreme single-stock dispersion overwhelmed a divergent tape as tech stocks split sharply between blockbuster earnings rallies and severe revenue-miss selloffs, leaving major in…

55% High dispersion dominated the session with 50 stocks surging an average 26.9% and 50 plunging 29.6%, reflecting a bifurcated market where earnings quality determined winners (STIM +51%, QMCO +47%, TISI +35%) versus decisive losers (ARCI -96%, VII -83%, PDSB -65%), a stock-picker's paradise masking broad flatness.
30% The broad market stayed eerily calm—S&P 500 -0.11%, NASDAQ -0.52%, Russell 2000 -0.32%—as fear metrics actually cooled with VIX dropping 3.4% despite the carnage in individual names, signaling that dispersion rather than systemic risk drove the day's action.
15% Technology exhibited internal conflict: the sector claimed 32% of gainers (including earnings beats from KOPN +24%, CRWV +17%, EROC +22%) but also 23% of losers (revenue misses like GCTS -18%, iHeartMedia -20%, Electrovaya -21%), highlighting that execution, not sector rotation, separated winners from debris.

Technology drove 32% of gainers 5 names returned after long absences DRMA — first appearance TISI — first appearance

Market Regime

Tue, Aug 11, 2026 Risk-On conf: medium macro · prototype

+47

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.3 p5 Drawdown-0.4% Held7d · established SinceAug 3

Top drivers: VIX percentile ▲ S&P vs 20d avg ▲ S&P vs 50d avg ▲

processId: history-market-regime

Market Indexes

Tue, Aug 11, 2026 13

S&P 500

7,728.20

−8.32

-0.11%

Dow Jones

53,791.85

−294.03

-0.54%

NASDAQ Composite

26,445.45

−139.55

-0.52%

NASDAQ 100

29,525.48

−207.68

-0.70%

DJ US Total Market

76,589.49

−33.88

-0.04%

Russell 1000

4,213.66

−0.03

0.00%

S&P MidCap 400

3,882.39

+13.98

+0.36%

Russell 2000

3,027.12

−9.87

-0.32%

Russell 2500

1,294.50

+3.24

+0.25%

Russell 3000

4,399.34

−0.63

-0.01%

Nasdaq Financial-100

7,545.58

+4.82

+0.06%

NIFTY 50

24,471.70

−152.95

-0.62%

VIX

15.28

−0.53

-3.35%

Biggest Gainers

Tue, Aug 11, 2026 50

ATHHF

Aether Catalyst Solutions Inc.Consumer Cyclical

$0.01+$0.00

+97.6%

STIM

ETFS 1X Daily Short TinHealthcare

$3.19+$1.11

+50.9%

NASDAQ · Mkt cap $239 M

Neuronetics reported strong Q2 2026 earnings with 9.1% revenue growth, positive adjusted EBITDA, and a narrower loss that beat expectations by 54.55%, driving a 50.91% gain in STIM shares on 2026-08-11.

The headlines establish that Neuronetics (ticker STIM) released Q2 2026 results on 2026-08-11 that significantly exceeded investor expectations. The company delivered a 54.55% earnings surprise and a 3.20% revenue beat, achieving positive adjusted EBITDA and reporting a sharply narrowed net loss. Revenue grew 9.1% year-over-year, driven by expansion of the Greenbrook clinic business despite a decline in NeuroStar revenue. Management also lowered full-year 2026 operating expense guidance. These operational improvements signal a turnaround narrative that matches the stock's 50.91% single-day jump. The earnings surprise magnitude and positive margin inflection appear to have triggered strong institutional and retail buying interest on the day of the announcement.

DRMA

Dermata Therapeutics, Inc. Common StockHealthcare

$1.10+$0.53

+47.7%

NASDAQ · Mkt cap $5.8 M

Dermata announced the August 25, 2026 commercial launch date of its first product, Tome Foundational Treatment, triggering a 47.75% rally as the company reached a major de-risking milestone.

The headline establishes that Dermata provided a corporate update and Q2 2026 financial results on August 11, with the material announcement being a confirmed launch date for Tome Foundational Treatment on August 25. For a clinical-stage or early-commercial biotech company, the transition from development to actual market availability represents a significant de-risking event and a concrete step toward revenue generation. The stock's strong ranking as the third biggest gainer suggests investor relief and enthusiasm about the imminent product availability. The company's presence at the Be+Well Beauty and Wellness Show signals active commercialization and market positioning. No negative guidance, missed milestones, or concerning financial details were mentioned in the headline.

QMCO

Quantum CorpTechnology

$19.39+$6.29

+47.0%

NASDAQ · Mkt cap $958 M

Quantum Corp reported fiscal Q1 2027 earnings that crushed estimates, posting 26% revenue growth, achieving first positive non-GAAP net income since 2023, and eliminating all debt, driving the stock up 47% on the surprise.

Quantum delivered a rare triple win: revenues beat guidance and prior expectations by 7.74%, earnings surprised to the upside by 205.88%, and the company achieved profitability on a non-GAAP basis for the first time in three years while simultaneously reaching a debt-free balance sheet. This combination of revenue acceleration, profit inflection, and balance sheet cleanup is exactly the type of fundamental inflection point that triggers sharp single-day rallies in mid-cap technology stocks, especially those recovering from prior struggles. The company cited strong demand for ActiveScale and tape storage products, though supply chain constraints prevented even higher fulfillment. The move ranks QMCO as the fourth largest gainer on NASDAQ for the day, suggesting broad institutional recognition of the turnaround narrative.

GLE

Global Engine Group Holding Limited Ordinary SharesTechnology

$0.49+$0.17

+46.1%

NASDAQ · Mkt cap $6.8 M

Global Engine Group announced a strategic collaboration with Angkasa-X to advance a space-to-AI edge infrastructure platform, advancing beyond a prior May memorandum of understanding toward a Sarawak proof-of-concept, which likely triggered the 46% gain.

The two nearly simultaneous announcements on August 11, 2026 describe GLE entering into a formal strategic collaboration agreement with Angkasa-X Holdings Corp. This represents a concrete step beyond the May memorandum of understanding toward an actual proof-of-concept project combining satellite ground stations, edge data center infrastructure, and AI data processing in Sarawak. For a micro-cap stock trading at $0.49, a partnership announcement in the high-growth space-to-AI infrastructure sector can generate outsized enthusiasm, particularly when it signals progression from preliminary MOU to actionable project scope. The timing of two coordinated press releases amplifies visibility. However, the headlines do not specify deal terms, funding commitments, timeline, or revenue recognition criteria, so the move appears driven by sentiment around strategic positioning rather than quantified financial impact.

WXM

WF International Limited Ordinary SharesIndustrials

$7.87+$1.78

+41.8%

KPET.WT

KPET Ultra Paceline Corporation WT

$0.70+$0.20

+40.0%

BOXL

Boxlight CorpTechnology

$2.94+$1.11

+38.0%

NASDAQ · Mkt cap $3.5 M

Boxlight announced the closing of a private placement on August 6, 2026, which likely triggered investor optimism around capital raising and near-term financing needs, driving the 38% single-day gain.

The headline confirms that Boxlight completed an initial closing of a private placement transaction on August 6, with the announcement released on August 11. Private placements typically signal management confidence and provide near-term liquidity for operations or strategic initiatives. For smaller-cap technology companies like Boxlight, successful capital raises often reduce near-term dilution concerns or bankruptcy risk and can fund product development or market expansion. The headline text is truncated and does not specify the deal size, terms, or use of proceeds, which limits precision in attribution. However, the timing alignment between the closing date and the announcement coupled with the ranking as 8 biggest gainer suggests the market responded positively to the financing news itself rather than to underlying operational performance.

AIFA

All In FutureTech Alliance, Inc.Technology

$3.17+$0.77

+35.6%

NASDAQ · Mkt cap $19 M

No news headlines were available in the last 48 hours to explain AIFA's 35.65% jump, so the catalyst remains unknown based on public market data.

The absence of recent news headlines means we cannot point to a specific earnings report, product announcement, acquisition, regulatory approval, or guidance change as the driver of this move. AIFA is a micro-cap stock on NASDAQ with limited institutional coverage, which makes it more susceptible to intraday volatility, retail trader momentum, and potentially rumor-driven moves that may not immediately appear in major news feeds. The jump could reflect delayed dissemination of company news, social media activity, technical breakout trading, options activity, or positions unwinding, but none of these can be confirmed without additional evidence. The stock's rank as the 9 biggest gainer suggests broad-based retail interest rather than a targeted institutional catalyst.

TISI

Team IncIndustrials

$22.70+$5.91

+35.2%

NYSE · Mkt cap $103 M

Team Inc surged 35% after announcing a major activist investment by Stellex Capital Management and unveiling a $20M-$35M cost savings plan, despite Q2 revenue missing expectations.

The earnings released on August 10-11 showed Q2 revenue of $229M down from $248M year-over-year, a miss that would typically pressure the stock. However, two offsetting catalysts appear to have driven the strong rally. First, Stellex Capital Management disclosed it became the largest common equity shareholder with a significant new investment, signaling activist confidence in the turnaround thesis. Second, management reaffirmed full-year guidance and announced a structured cost reduction program targeting $20M-$35M in savings, positioning the company as focused on operational efficiency despite near-term headwinds. The combination of activist endorsement and a credible cost-cutting roadmap appears to have convinced the market that near-term revenue softness is temporary and management has a clear path to profitability improvement.

XHLD

TEN Holdings, Inc. Common StockCommunication Services

$3.53+$1.05

+35.0%

NASDAQ · Mkt cap $92 M

TEN Holdings reported second quarter 2026 financial results on August 10, likely triggering the 35% gain, though the headline excerpt does not disclose specific earnings metrics, guidance, or whether results beat or missed expectations.

The stock's 35% jump ranks it eleventh among daily gainers and coincides directly with the company's Q2 2026 earnings release on August 10. The headline confirms TEN Holdings, an event technology company serving enterprise customers with virtual, hybrid, and webinar platforms, published results. However, the provided excerpt is truncated and does not include the actual financial figures, profit/loss, revenue growth, guidance changes, or management commentary that would explain investor enthusiasm. A 35% single-day rally typically follows positive surprise earnings, an upside revenue beat, raised full-year guidance, or a major contract win. Without access to the full earnings release, we cannot determine which of these catalysts drove the move. It is possible the market had been pessimistic and results simply met or modestly exceeded depressed expectations, or the company delivered materially strong forward guidance.

RIBBR

Ribbon Acquisition Corp Rights

$0.27+$0.07

+32.7%

NASDAQ · Mkt cap $1.2 M

No news was published in the last 48 hours, but Ribbon Acquisition Corp Rights is a SPAC-related instrument whose value is highly sensitive to movements in the underlying warrant or merger developments, making a 33% single-day jump typical for these volatile, illiquid securities.

No headlines appear in the provided news feed for the past 48 hours, so we cannot attribute the move to a specific announced event. However, Ribbon Acquisition Corp Rights is a derivative instrument tied to a SPAC merger process. These rights are inherently volatile and trade on relatively low volume, making them prone to sharp percentage swings from small absolute dollar moves, shifts in the underlying warrant's price, or speculative trading around merger timelines or shareholder votes. The jump could reflect renewed merger momentum, a deadline approaching, retail interest sparked by social media or a trading alert, or simply a thin-order-book snap upward on modest buying volume. Without accompanying news, any specific explanation remains speculative.

SYRA

Syra Health Corp. - Class A Common StockHealthcare

$0.87+$0.21

+30.8%

NASDAQ · Mkt cap $11 M

Syra Health reported 23% revenue growth and achieved its second consecutive profitable quarter with improved gross margins of 44.5%, driving a 30.83% rally as the market rewarded expanding profitability and operational momentum.

The headline from August 11, 2026 directly establishes that Syra Health announced strong second-quarter results featuring 23% year-over-year revenue growth, a 44.5% gross margin (an improvement suggesting better pricing power or cost control), and confirmation of profitable operations sustained into a second consecutive quarter. For a small-cap healthcare company trading at $0.87 per share, achievement of consistent profitability alongside double-digit revenue acceleration represents a meaningful inflection point. The market appears to have interpreted this as validation that the company's integrated healthcare model is working operationally and financially. The 30.83% single-day gain is a typical magnitude for small-cap health tech stocks when they cross into sustained profitability with accelerating growth, especially after what may have been a period of losses or breakeven performance.

ALMR

Alamar Biosciences, Inc.Healthcare

$36.49+$8.59

+30.8%

NASDAQ · Mkt cap $2.1 B

Alamar Biosciences jumped 30.79% following Q2 earnings that beat expectations with 82% revenue growth, record 60% gross margins, and an expanded partnership with the Alzheimer's Disease Data Initiative, positioning the company for 59% annual growth.

The earnings report released on August 10th shows strong operational momentum across consumables, instruments, and services. Q2 revenue of $29.4 million exceeded the prior year period by 82%, and management provided full-year 2026 guidance implying 59% growth. The company achieved a record 60% gross margin, demonstrating pricing power and operational leverage. Additionally, the expanded partnership with the Alzheimer's Disease Data Initiative and Gates Ventures to profile 86,000 additional samples validates market demand for the company's precision proteomics platform. While the headlines note that net losses are widening and near-term margins may fluctuate, the combination of accelerating top-line growth, expanding partnerships, and record gross margins appears to have outweighed valuation concerns that were flagged in a separate article noting the stock trades at a premium to sales.

AIHS

Senmiao Technology LtdIndustrials

$1.85+$0.44

+30.6%

NASDAQ · Mkt cap $21 M

Senmiao announced a $5 million partnership with Elio Energy Group to develop the Energence Utah data center campus, targeting 100 MW of capacity initially and up to 1.2 GW by Year 6, driving strong investor enthusiasm for the company's digital infrastructure pivot.

The two nearly simultaneous announcements on August 11 describe the same partnership agreement: a staged $5 million investment giving Senmiao an initial position in a Utah-based data center and energy development project. The headlines establish that the company is pursuing a material expansion into digital infrastructure, a sector with significant investor appeal given current market trends around AI, cloud computing, and energy demand. The scale of the opportunity (1.2 GW target by Year 6) and the partnership with an established energy developer appear to have resonated with the market. The 30.56% single-day gain ranks among the day's top gainers, suggesting this was a significant positive catalyst for a stock that trades at relatively low absolute price levels and may have a smaller float, amplifying percentage moves.

AIAI

AIAI Holdings CorporationIndustrials

$5.42+$1.17

+28.0%

NASDAQ · Mkt cap $367 M

AIAI Holdings announced the launch of Dôr, an AI-powered retail intelligence platform integrating customer traffic, POS, labor, marketing and weather data, likely driving the 28% gain as a concrete product milestone demonstrating operational execution.

The headline establishes that AIAI's Constellation Network has launched a new product called Dôr designed to help retailers identify missed demand and optimize operations across single or multiple locations. This is a tangible business development announcement showing the company is moving from concept to deployed solution. For a small-cap AI software company trading at $5.42, a major product launch that addresses a real retail pain point (reconciling traffic, sales, staffing and external factors) can catalyze significant upside momentum, especially if investors perceive it as evidence of market traction or competitive differentiation. The timing aligns perfectly with the stock's +28% intraday move. However, the headline does not disclose customer wins, revenue impact, or pricing details that would further validate the product's commercial viability, so the rally may also reflect speculative enthusiasm rather than proven demand.

KPLT

Katapult Holdings, Inc.Technology

$7.93+$1.57

+24.7%

NASDAQ · Mkt cap $29 M

Katapult completed a major three-way business combination with Aaron's and CCF Holdings on August 11, creating a $4 billion nonprime financial platform, which triggered the 24.69% stock surge as a direct result of deal closure.

The news headlines establish that Katapult finalized an all-stock merger combining three businesses into a scaled omnichannel platform. The enlarged entity reports pro forma 2025 revenue exceeding $4 billion and adjusted EBITDA above $460 million. This is a transformational M&A event that consolidates complementary retail, digital, and lease-to-own capabilities to serve nonprime consumers. Investors appear to have reacted positively to the completion of a deal that was previously announced, likely viewing the combined entity's scale, revenue base, and profitability metrics as validating the strategic thesis. The stock's jump to 17 biggest gainer reflects investor enthusiasm for the enlarged platform and improved competitive positioning in the nonprime financial services market.

ALEC

Alector IncHealthcare

$2.09+$0.41

+24.5%

NASDAQ · Mkt cap $271 M

No news headlines were found in the last 48 hours, so the 24.48% gain cannot be directly attributed to a disclosed catalyst. The move likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or an undisclosed development.

Alector Inc experienced a significant single-day jump of nearly 25%, ranking it among the top 20 gainers on NASDAQ, yet no recent news headlines are available to explain the move. This disconnect between price action and publicly reported information suggests several possibilities. First, the catalyst could be a delayed market reaction to a company announcement from more than 48 hours prior that is only now gaining traction. Second, as a clinical-stage biotech company, Alector stock is typically responsive to clinical trial data, regulatory updates from the FDA, or strategic partnership announcements—categories of news that sometimes emerge through channels beyond standard financial wire coverage. Third, the move could reflect technical factors such as short covering, options-related gamma effects, or algorithmic trading patterns in a thinly traded security. Without access to the underlying catalyst, attribution remains speculative.

BAOS

Baosheng Media Group Holdings Limited Ordinary sharesCommunication Services

$0.73+$0.17

+24.3%

NASDAQ · Mkt cap $799 K

No news headlines were published in the last 48 hours for BAOS, so the 24% gain cannot be attributed to a documented catalyst. The jump likely reflects technical trading, short covering, or undisclosed company developments.

The absence of any news in the Yahoo Finance RSS feed over the past two days means we cannot point to a specific earnings release, contract win, regulatory action, or guidance change to explain the 24% spike. For a micro-cap stock like BAOS trading near $0.73, several generic mechanisms could drive such moves: technical oversold conditions triggering algorithmic reversals, short-squeeze activity if the float is tight, delayed dissemination of company announcements not yet indexed by major news aggregators, or retail trading momentum on social platforms. Without documented headlines or knowledge of BAOS's shareholder structure and trading patterns, we cannot distinguish between these scenarios. The rank as the 19th biggest gainer suggests this was a genuine intra-day mover, not a data error, but the cause remains opaque to public information sources monitored here.

VELO

Velocity Acquisition Corp.Technology

$13.69+$3.12

+23.9%

NASDAQ · Mkt cap $447 M

Velo3D announced Q2 2026 financial results on August 11, likely triggering a 23.85% rally if the results beat expectations or included positive guidance for the aerospace and defense additive manufacturing market.

The news headline confirms Velo3D released second quarter 2026 financial results on the same day as the stock's surge. The press release was issued at 20:05 UTC, which aligns with the trading action captured in this snapshot. Without access to the full earnings report, the specific revenue, profitability, or guidance figures, we cannot confirm whether the rally was driven by an earnings beat, margin expansion, strong forward guidance, new customer wins, or simply sentiment improvement in the additive manufacturing sector. The company operates in aerospace and defense, sectors that can see outsized reactions to operational milestones. The 23.85% gain suggests material positive surprise rather than routine quarterly disclosure, but the exact financial metrics and management commentary driving the move remain unspecified in the available headline excerpt.

KOPN

Kopin CorpTechnology

$5.20+$0.99

+23.5%

NASDAQ · Mkt cap $794 M

Kopin surged 23.54% on strong Q2 earnings (51% revenue growth) plus a high-profile partnership announcement with Fabric.AI to co-develop MicroLED optical interconnect technology for AI infrastructure, with a public demonstration planned for CES 2027.

The catalyst is multifaceted but grounded in concrete business wins. Kopin reported Q2 2026 revenue growth of 51% year-over-year, driven by government-funded MicroLED development and its collaboration with Fabric.AI. More importantly, on the same day the company announced a formal partnership with Fabric.AI to develop Neural I/O MicroLED optical interconnect technology targeted at AI infrastructure connectivity, with a working demonstration committed for CES 2027. This signals Kopin has secured a major partnership that validates its core MicroLED technology in a new, high-growth market (AI infrastructure rather than just defense or AR). The earnings beat combined with this strategic validation of commercial relevance in a hot sector explains the sharp single-day move. The company also appears to be approaching GAAP profitability by Q4 2026, removing a major valuation overhang.

FRTT

Fort Technology Inc.Consumer Cyclical

$1.28+$0.23

+23.5%

NASDAQ · Mkt cap $11 M

Fort Technology announced the acquisition of Logia USA, a fuel integrity solutions provider for data centers, on August 11, 2026, likely driving the 23.52% stock gain as investors reacted positively to the strategic M&A move.

Fort Technology announced a share transfer agreement to acquire Logia USA, which provides fuel integrity solutions for data centers. This is a concrete M&A event announced on the same day as the stock's significant jump, making it the most plausible catalyst for the gain. The acquisition appears to be a growth-oriented strategic move in the data center infrastructure space, which has been a strong sector. The headline was published at 12:00 UTC on August 11, consistent with the snapshot date. Without details on valuation, financing, or expected earnings accretion, we cannot assess whether the market's reaction is justified fundamentally, but positive M&A announcements commonly drive intraday rallies, particularly in smaller-cap stocks like FRTT where news flow is sparse and events are more material to valuations.

SEPN

Septerna, Inc. Common StockHealthcare

$47.79+$8.91

+22.9%

NASDAQ · Mkt cap $1.9 B

Septerna reported better-than-expected Q2 revenue (up 30% versus estimates) and announced positive clinical progress on its lead drug SEP-479, which supports a once-daily oral dosing profile with Phase 1 data on track for Q1 2027, triggering broad investor enthusiasm for the biotech pipeline.

Septerna released second-quarter 2026 results showing a 30.07% revenue beat and 39.58% earnings surprise on August 10th after market close. The company reported ongoing Phase 1 clinical trial progress for SEP-479, an oral small-molecule PTH1R agonist, with clinical pharmacokinetic data supporting once-daily dosing—a clinically meaningful advantage for patient compliance. Safety and efficacy data (SAD/MAD) are expected in Q1 2027, which provides a near-term catalyst for the stock. The company also disclosed a strong cash position of $516.5 million, reducing near-term funding risk. For early-stage biotech firms, revenue beats combined with clinical progress on lead candidates and robust cash runway typically drive significant single-day rallies as investors reprice upside probability for late-stage development wins.

HQI

HireQuest IncIndustrials

$17.00+$3.10

+22.3%

NASDAQ · Mkt cap $232 M

HireQuest reported better-than-expected Q2 earnings with a 76.92% earnings beat, return to revenue growth after nearly two years, and net income more than doubling year-over-year, driving a strong market response on staffing demand recovery.

The 22.30% gain directly follows HireQuest's Q2 2026 earnings release, which delivered substantial upside surprises on both metrics. The company reported earnings per share that beat estimates by 76.92% and revenue that exceeded expectations by 18.06%. More significantly, this marks the first quarter of revenue growth since Q3 2024, suggesting a reversal of a multi-quarter revenue contraction trend. Management commentary highlighted improving demand for temporary staffing services, with particular strength noted in the latter half of the quarter, signaling positive momentum into the second half of 2026. The doubling of net income year-over-year indicates not just top-line recovery but meaningful operational leverage and margin improvement. This combination of surprise profitability, growth resumption, and forward-looking demand commentary appears sufficient to justify the strong single-day move in a previously struggling staffing services franchisor.

VEEE

Twin Vee Powercats Co.Consumer Cyclical

$12.70+$2.21

+22.0%

NASDAQ · Mkt cap $6.2 M

Twin Vee Powercats stock surged 21.97% on August 11, 2026, but no news headlines were found in the prior 48 hours to explain the move, making the specific catalyst unclear.

The absence of recent news headlines in the 48-hour window before this 22% gain creates a genuine gap in our ability to identify the catalyst. Twin Vee Powercats is a relatively small-cap boat manufacturer, and stocks in this category can be sensitive to several types of unleveraged catalysts: announced contracts or large orders, quarterly earnings releases (even if not yet widely syndicated), management commentary at conferences or investor calls, improved dealer sentiment, or supply-chain updates affecting production timelines. Alternatively, the move could reflect technical factors such as short covering (the stock may have been shorted given its small float and volatility profile), or delayed news distribution that hasn't yet propagated to widely tracked feeds. Without access to company press releases, SEC filings, or broker research notes from the exact timing of market open on August 11, we cannot isolate the trigger.

EROC

ERock, Inc.Industrials

$11.22+$2.29

+21.7%

NYSE · Mkt cap $3.2 B

ERock surged 21.71% after securing Anthropic as its largest customer, with a major contract for modular gas-fired generators announced on the same trading day, marking a significant validation for the power-generation company following its rough IPO.

The headline establishes that Anthropic, a major AI company, has agreed to purchase ERock's modular gas-fired generators in what is described as the power-generation company's largest contract to date. This represents concrete revenue validation and a marquee customer win for ERock, a recently IPO'd firm that reportedly had a difficult market debut. Large customer wins, especially from well-capitalized tech firms with substantial power needs, typically signal strong demand for the company's products and improve near-term revenue visibility and profitability expectations. The timing of the announcement on the same day as the 21.71% jump strongly suggests investor confidence in both the contract terms and ERock's ability to execute on this relationship.

ACB

Aurora Cannabis IncHealthcare

$3.49+$0.61

+21.0%

NASDAQ · Mkt cap $248 M

Curaleaf launched a hostile takeover bid for Aurora Cannabis at $4.00 per share on August 11, representing a 45% premium to the 30-day VWAP, directly triggering the 21% single-day rally.

The news is unambiguous and tightly time-stamped. Curaleaf announced its intention to acquire Aurora Cannabis through an unsolicited takeover bid valued at US$4 per share in a combination of cash and stock. Multiple sources confirm the announcement occurred on August 11, 2026, with the first press release at 12:00 UTC and subsequent updates through 20:08 UTC the same day. Aurora issued a formal response acknowledging receipt of Curaleaf's bid announcement. The 45% premium to the 30-day VWAP is explicitly stated in one headline. This is a classic M&A catalyst: unsolicited bids at significant premiums typically drive immediate share price appreciation as investors price in either acceptance, a bidding war, or a successful completion at or above the offer price. The timing between the bid announcement and the stock's 21% jump aligns perfectly.

KUST

Kustom Entertainment IncCommunication Services

$1.33+$0.23

+21.0%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours for KUST, so the 21% gain on August 11 cannot be traced to a specific announced catalyst. The move likely reflects technical or sentiment-driven trading in a micro-cap stock.

KUST gained 21% with zero associated news headlines in the Yahoo Finance RSS feed over the relevant period. For a micro-cap entertainment stock ranking as the 28th biggest gainer of the day, the absence of news does not rule out a catalyst—it may indicate delayed news dissemination, a press release issued outside major news wires, insider activity, short covering, or retail sentiment shifts. Entertainment and media stocks can be volatile on sentiment alone. Without access to company filings, insider trading reports, or social media discussion for the snapshot date, we cannot identify whether this was driven by technical momentum, a delayed announcement, sector rotation, or speculative trading. The stock's low price point ($1.33) suggests it may be thinly traded and susceptible to outsized percentage moves on modest volume or sentiment changes.

NIQ

Nuveen Intermediate Duration Quality Municipal Term FundTechnology

$16.58+$2.88

+20.9%

NYSE · Mkt cap $5.6 B

NIQ Global Intelligence reported strong Q2 2026 earnings that beat guidance across all key metrics with 5.8% organic revenue growth and raised full-year guidance, triggering the 20.93% rally on August 10-11.

The headlines establish that NIQ delivered second-quarter 2026 results that exceeded expectations, posting earnings surprises of +28.57% and revenue surprises of +1.57%. The company achieved 5.8% organic constant-currency revenue growth and a 21.9% increase in adjusted EBIT. Critically, NIQ raised its full-year guidance across all key metrics and extended a streak of beating top-end expectations to five consecutive quarters. One headline refers to "the narrative surrounding NIQ stock just shifted in a big way," which aligns with a positive guidance raise and sustained execution beat. This type of earnings acceleration combined with raised forward guidance typically justifies significant single-day gains, especially when a company demonstrates consistent outperformance over multiple quarters.

LESL

Leslie''s IncConsumer Cyclical

$1.33+$0.23

+20.4%

NASDAQ · Mkt cap $6.1 M

No news headlines were found in the last 48 hours, so the 20% gain cannot be attributed to any documented public announcement. The move may reflect technical bounce, short covering, or delayed market reaction to an earlier event.

Leslie's Inc (LESL) jumped 20.36% to rank among the day's top 30 gainers, yet no recent news was available in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect suggests either that the catalyst was not covered by major news outlets, occurred before the 48-hour window, or reflects purely technical/trading dynamics. Historically, pool and spa retailers are cyclical, sensitive to consumer spending and seasonal demand, but without specific earnings results, guidance updates, or operational announcements, we cannot pinpoint a fundamental trigger. The move could represent a rebound from oversold conditions, algorithmic accumulation, short-squeeze activity, or reaction to news published through non-RSS channels not captured in the provided data.

HYLN

Hyliion Holdings Corp.Consumer Cyclical

$3.94+$0.79

+19.8%

BWEN

Broadwind Energy IncIndustrials

$5.34+$0.88

+19.7%

NASDAQ · Mkt cap $115 M

Broadwind stock surged 19.73% after the company reported sharply higher Q2 revenue, improved adjusted EBITDA, and record order activity, despite initial market disappointment over a revenue miss earlier in the day.

The timeline reveals initial selling pressure when Q2 earnings were announced at 11:00 AM, with headlines noting a revenue miss of 28.52% versus estimates and a 200% earnings surprise (loss). Stock fell roughly 6% on that news. However, by end of day the stock was up nearly 20%, suggesting a significant revaluation occurred during or after the earnings call. The subsequent headlines from the 14:22 and 16:04 updates highlight that despite the revenue shortfall, management delivered positive guidance on operational metrics: sharply higher revenue growth, improved adjusted EBITDA, and notably "record order activity" in its Gearing and Industrial Solutions divisions. Investors appear to have initially reacted to the headline miss but then re-rated the stock higher based on forward-looking indicators and profitability improvements communicated during the call itself.

OMH

Ohmyhome Limited - Ordinary SharesReal Estate

$0.11+$0.02

+19.6%

NASDAQ · Mkt cap $7.7 M

No news was published in the last 48 hours for OMH, so the +19.59% gain cannot be directly attributed to a disclosed catalyst. The jump likely reflects either a technical rebound, low-volume trading in a micro-cap, or undisclosed market activity.

OMH is a micro-cap stock trading at $0.11, which makes it highly susceptible to outsized percentage moves on minimal absolute dollar volume. Without any news headlines in the past 48 hours, the gain is not anchored to a specific announced event such as earnings, a contract win, or strategic news. Possible causes include technical oversold conditions triggering a bounce, a short squeeze in a thinly traded security, retail interest driven by social media or chat platforms not reflected in official news feeds, or delayed market reaction to an announcement that has not yet surfaced on Yahoo Finance RSS. Very low-priced stocks often exhibit wild swings independent of company fundamentals.

TAOP

Taoping IncTechnology

$0.86+$0.14

+19.1%

NASDAQ · Mkt cap $7.9 M

Taoping announced a new Smart Elevator Insurance Pilot Program on August 10, which likely drove the 19.13% gain as investors responded positively to expansion into a new revenue-generating business vertical.

The headline indicates Taoping launched a pilot program for smart elevator insurance through its subsidiary, representing a diversification move into the insurance sector. This is a tangible business development announcement that could signal new revenue streams and market expansion beyond the company's traditional cloud-based technology and IoT platform offerings. For a micro-cap stock trading at $0.86, a new product line announcement can generate outsized enthusiasm, particularly if it suggests the company is pivoting into higher-margin or recurring revenue models like insurance. However, the news headline provided is truncated and lacks detail on program scope, expected financial impact, or timeline, so the full context of investor enthusiasm remains partially opaque. The timing between the announcement (August 10 midday) and the price move (reflected in the August 11 snapshot) aligns logically with a market reaction to this news.

GRI

Cohen & Steers Global Realty Majors ETFHealthcare

$2.19+$0.35

+19.1%

NASDAQ · Mkt cap $3.1 M

No news headlines were found in the last 48 hours for GRI, so the 19.13% gain likely reflects broad real estate sector strength, market-wide equity recovery, or technical/momentum trading in this ETF.

The absence of any news in the Yahoo Finance RSS feed over the last two days means we cannot point to a specific company announcement, earnings report, or sector catalyst. GRI is a passively managed ETF tracking global real estate majors, so its price moves typically track underlying real estate equities and broader risk sentiment. A jump of this magnitude on no named news could reflect several factors: a broad rally in real estate stocks driven by macroeconomic shifts (interest rate expectations, inflation data, or credit market movements), a catch-up move after prior weakness, or technical buying in a popular ETF. Real estate equities are sensitive to interest rate expectations and economic data; any positive macro signal in the last 48 hours would ripple through the sector. Without headline confirmation, however, we are inferring the likely driver category rather than identifying a specific event.

BSIN

Big Sky Industrial IncEnergy

$1.44+$0.23

+19.0%

NASDAQ · Mkt cap $73 M

Big Sky Industrial reported Q2 earnings on August 11 with positive Phase 1 construction progress, secured helium offtake contracts, and a doubled credit facility, likely driving the 19% gain as investors rewarded progress toward first revenue in Q1 2027.

The three earnings headlines from August 11 establish that Big Sky Industrial disclosed material positive developments: Phase 1 construction advancement toward targeted first revenue in Q1 2027, a five-year 100% take-or-pay helium offtake agreement providing contracted initial revenue, and a doubled credit facility supporting liquidity. These represent concrete de-risking events for a capital-intensive industrial gas and carbon management project. The company also navigates pending EPA approvals and acknowledged a tight liquidity position, but the secured offtake and expanded credit facility appear to have outweighed near-term concerns. The timing of the move on the earnings release date strongly connects the stock action to this news flow rather than external market factors.

UAC.WT

$0.89+$0.14

+18.7%

ONTX

Onconova Therapeutics IncFinancial Services

$21.31+$3.30

+18.3%

Mistras Group IncIndustrials

$18.64+$2.87

+18.2%

NYSE · Mkt cap $607 M

Mistras Group reported Q2 2026 earnings on August 10-11 with revenue growth of 4.2%, record adjusted EBITDA of $25.8 million, and expanded gross margins, driving an 18.2% single-day gain as aerospace-defense and infrastructure segments offset weakness in oil and gas.

The earnings headlines establish that Mistras delivered multiple positive metrics in Q2 2026: continued revenue growth, record adjusted EBITDA, margin expansion of 10 basis points to 29.2%, and GAAP net income of $7.6 million ($0.23 per diluted share). The company achieved this while managing a headwind in its oil and gas segment, with gains in faster-growing end markets like aerospace-defense and infrastructure. The +18.2% move ranks as the 39th biggest gainer on the day, suggesting this was a clear earnings beat or raise relative to market expectations. The timing of the three news items (announcement on August 10, earnings call summary and highlights on August 11) aligns with a standard earnings release and call cycle, and the stock's strong reaction suggests investors rewarded the diversification away from oil and gas and the EBITDA expansion.

NRGV

Energy Vault Holdings, Inc.Utilities

$3.60+$0.62

+18.1%

NYSE · Mkt cap $689 M

Energy Vault reported Q2 2026 results and raised full-year 2026 revenue and gross margin guidance, driving an 18% intraday gain as investors rewarded the improved outlook.

The headline confirms Energy Vault released second-quarter financial results on August 11, 2026, and crucially raised its full-year revenue and gross margin guidance. This is a textbook positive catalyst for equity investors: beaten or met quarterly results coupled with upward guidance revision signals management confidence in accelerating demand and improving unit economics. The company operates in grid-scale energy storage and AI compute infrastructure, sectors benefiting from growing demand for renewable integration and data center power. The specific numbers (Q2 earnings, margin improvement, FY guidance raise) are not fully detailed in the headline, but the structural signal—management raising forward guidance—typically triggers re-rating in growth-oriented stocks. The 18% single-day move is substantial but not anomalous for a smaller-cap energy storage play responding to positive guidance revision.

HRB

H&R Block IncConsumer Cyclical

$46.70+$8.33

+18.0%

NYSE · Mkt cap $6.3 B

H&R Block reported Q2 revenue above expectations with 5% full-year revenue growth, raised its quarterly dividend by 10%, and returned $714M to shareholders, driving an 18% stock jump on investor confidence in execution.

H&R Block delivered earnings results on August 11 that beat sales expectations with Q2 revenue of $1.14 billion, up 3% year-over-year, and raised full-year guidance to $4.14 billion. Beyond the revenue beat, the company demonstrated shareholder-friendly capital allocation by returning $714 million through dividends and buybacks while raising the quarterly dividend by 10%. The combination of revenue growth, strong operating cash flow up 23%, and proactive dividend increases signals management confidence in near-term performance and cash generation. For a mature tax preparation business, this blend of organic growth, operational efficiency gains, and capital returns appears to have resonated strongly with investors, particularly those who may have been concerned about the cyclical nature of the tax business or dividend sustainability.

EXYN

Exyn Technologies, Inc.Technology

$2.58+$0.39

+17.8%

NASDAQ · Mkt cap $16 M

No news headlines were found in the last 48 hours, so the 17.81% gain cannot be attributed to a specific announced event. The move likely reflects technical trading, delayed news propagation, or market speculation in a small-cap stock.

Exyn Technologies gained nearly 18% on August 11, 2026, but no corresponding headlines appear in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect is common in small-cap and micro-cap stocks, where price moves can precede formal news announcements, reflect after-hours developments not yet indexed by mainstream sources, or result from technical factors such as short covering, options expiry flows, or retail momentum trading. Exyn operates in autonomous systems and robotics—sectors that can attract speculative interest during periods of AI enthusiasm or contract announcements. Without concrete news, the proximate cause remains unknown; the gain is more likely driven by technical or sentiment-based factors than a fundamental business development.

AIRS

AirSculpt Technologies, Inc.Healthcare

$3.22+$0.48

+17.5%

NASDAQ · Mkt cap $203 M

AirSculpt fell 13% on August 10th after missing revenue expectations and weakening its EBITDA outlook, but recovered sharply on August 11th, likely due to oversold technical rebound and investors reassessing the miss as priced in.

The stock sank 13% intraday on August 10th following Q2 earnings that showed revenue of $42.9 million down 2.5% year-over-year and disappointing EBITDA guidance, despite positive same-center case growth of 1%. The 17.52% jump the following day suggests a classic oversold bounce or a reassessment of the earnings miss as already reflected in the valuation. The positive same-center case metric may have encouraged longer-term investors to view the guidance as conservative or cyclical weakness. Without additional news on August 11th, the rebound appears driven by technical mean reversion and sentiment shift rather than new fundamental catalysts, though sentiment could have stabilized after the initial panic selling.

FENC

Fennec Pharmaceuticals IncHealthcare

$12.79+$1.87

+17.1%

NASDAQ · Mkt cap $416 M

Fennec Pharmaceuticals surged 17% on August 11 after reporting Q2 2026 earnings that beat analyst expectations, with net product sales up 78% year-over-year to $17.1 million and record EBITDA plus positive EPS, signaling strong commercial traction for PEDMARK.

Fennec released second-quarter financial results on August 11 showing substantial revenue growth and profitability metrics that exceeded market expectations. Net product sales of $17.1 million represented a 78% increase from the prior year, with the company achieving both record adjusted EBITDA of $2.8 million and positive earnings per share for the quarter. The earnings call highlights emphasized record demand for PEDMARK (the company's core product) extending into Q3. Multiple news sources noted earnings and revenue beats, with one report citing a +400% earnings surprise and +11.74% revenue surprise, indicating the results substantially outpaced consensus estimates. The company also provided a business update noting aggressive commercial expansion, which likely reinforced investor confidence in the commercial execution and near-term growth trajectory.

ADOC

Edoc Acquisition Corp.Financial Services

$0.48+$0.07

+17.1%

SLND

Southland Holdings, Inc.Industrials

$0.72+$0.10

+16.8%

NYSE · Mkt cap $32 M

No relevant news for SLND was provided; the 16.78% gain likely reflects technical/short-squeeze activity, sector rotation, or an unmentioned company-specific announcement not captured in the available headlines.

The only news headline provided concerns Janus International Group (JBI), a competitor in equipment leasing and modular space solutions, which beat earnings estimates. However, this news is about JBI, not SLND, and there is no direct evidence linking JBI's earnings surprise to SLND's sharp one-day move. It is possible that JBI's strong results improved sentiment across the modular/containment equipment sector and lifted SLND by association, but this remains speculative. More likely causes include technical momentum in a low-priced stock, short covering, or an unmentioned company-specific catalyst not included in the news feed. Without direct news about SLND itself, the true driver cannot be identified from the evidence at hand.

GANX

Gain Therapeutics, Inc.Healthcare

$2.06+$0.30

+16.7%

NASDAQ · Mkt cap $90 M

Gain Therapeutics released second quarter 2026 financial results and a corporate update on August 11th, which appears to have driven the 16.71% intraday gain, though the specific details of the announcement are not provided in the headline excerpt.

The company released Q2 2026 earnings and a corporate update on the morning of August 11th, coinciding precisely with the stock's 16.71% jump to rank among the day's top 50 gainers. For a clinical-stage biotechnology company, positive catalysts typically include pipeline progress announcements, cash runway updates, partnership news, or improved financial positioning. The headline indicates this was a material corporate announcement, but the full text is truncated and does not reveal whether the move was driven by clinical trial advancement, funding news, operational metrics, or guidance. Without access to the complete earnings release or transcript, the exact nature of the positive catalyst cannot be definitively established, though the timing alignment between the announcement and the stock move is clear.

CRWV

CoreWeave, Inc. Class A Common StockTechnology

$90.32+$14.57

+16.6%

NASDAQ · Mkt cap $48 B

CoreWeave reported Q2 2026 earnings that beat revenue estimates and delivered a smaller-than-expected loss with better-than-expected operating margins, driven by surging AI infrastructure demand, triggering the 16.62% gain.

CoreWeave released second-quarter results on August 11, 2026, that exceeded Wall Street expectations on multiple fronts. Revenue more than doubled to $2.58 billion, topping analyst estimates, while the adjusted net loss came in at $567 million versus the $670 million consensus expectation. Critically, adjusted operating income of $128 million exceeded the $70 million estimate, signaling improving unit economics and operational leverage. The earnings beat occurred amid strong demand for AI cloud computing infrastructure, with the company adding more customers in a booming AI market. Multiple analyst commentators and news sources framed the results as a positive inflection point, with D.A. Davidson's Gil Luria noting the company took a step in the right direction. The combination of revenue upside, loss compression, and margin expansion in a high-growth AI infrastructure category drove the post-earnings rally.

IMTE

Integrated Media Technology LtdTechnology

$0.47+$0.07

+16.6%

NASDAQ · Mkt cap $1.7 M

No news headlines were found in the last 48 hours, so the 16.59% gain likely reflects either a delayed market reaction to older news, technical trading, or untracked catalysts specific to this small-cap stock.

Integrated Media Technology is a micro-cap stock trading at $0.47, and no material news appeared in the Yahoo Finance RSS feed during the snapshot window. This absence of headlines does not rule out a catalyst; it may indicate that relevant news was released outside the tracked sources, was announced before the 48-hour window, or failed to generate major press coverage. Micro-cap and penny stocks often experience sharp moves driven by technical factors such as short covering, options expiration, or small volume flows that create outsized percentage swings. Alternatively, the move could reflect delayed market digestion of company-specific developments or unconfirmed rumors circulating among retail traders, neither of which would appear in mainstream financial news feeds. Without access to the company's official announcements, SEC filings, or trading volume data, any explanation remains speculative.

OPTX

Syntec Optics Holdings, Inc.Technology

$8.88+$1.26

+16.5%

NASDAQ · Mkt cap $337 M

Syntec Optics reported all-time high Q2 2026 revenue with expanded margins, positive earnings, a strengthened balance sheet, and raised forward guidance on August 10, driving the 16.54% gain.

The headline directly attributes the stock's move to a strong quarterly earnings release. Syntec Optics announced record revenue in Q2 2026 alongside multiple positive metrics: margin expansion, higher profitability (positive earnings), balance sheet improvements, and raised revenue guidance for future periods. All four elements are classic drivers of equity appreciation, and the combination of beat-and-raise guidance is particularly powerful for investor sentiment. The timing aligns precisely—the news released August 10 at 20:33 UTC, and the stock gained 16.54% on the August 11 trading session. No conflicting news or offsetting factors appear in the provided headlines.

Biggest Losers

Tue, Aug 11, 2026 50

ARCI

Appliance Recycling Centers of America IncFinancial Services

$10.17−$9.74

-95.8%

VII

7GC & Co. Holdings Inc.Financial Services

$1.70−$8.11

-82.7%

PDSB

PDS Biotechnology CorpHealthcare

$0.26−$0.47

-64.7%

NASDAQ · Mkt cap $11 M

PDS Biotechnology announced a strategic refocus narrowing its pipeline to prioritize PDS0301 in metastatic colorectal cancer while pivoting PDS0101 to a partnership model, signaling a significant capital reallocation that triggered the 64.67% sell-off.

The company's announcement on August 11 detailed a strategic refocus driven by Phase 2 clinical data in mCRC and a comprehensive review of capital allocation priorities. This type of announcement typically signals that management is retreating from broader development plans and concentrating resources on fewer programs, which often reflects either disappointing clinical results, cash constraints, or both. The framing as "maximize long-term shareholder value" is standard language for such pivots, but the market's interpretation—a two-thirds decline in a single day—suggests investors viewed the narrowed focus as a negative signal about the program's commercial prospects, the company's cash runway, or both. Without access to the full clinical data details or the specific terms of the PDS0101 partnership strategy, the exact reason for the sharp repricing is not entirely clear from the headline alone.

MYSEW

MYSEWTechnology

$0.00−$0.01

-60.8%

NASDAQ

MYSEW dropped 60.78% despite announcing a partnership with major non-profits to expand its Picture Party platform user base to 1.6 million members; the disconnect between positive partnership news and severe stock decline suggests the market either disbelieves the deal's impact, has concerns unre…

The headline describes what appears to be a substantive business development—a partnership with established organizations like Special Olympics, YMCA, and Junior Achievement that collectively reach over 1.6 million potential users. This type of user acquisition platform announcement would typically be viewed as positive for a consumer-facing application. However, a 60.78% single-day drop contradicts this narrative entirely. Possible explanations include: first, the market may view the partnership as insufficient to address deeper unit economics or revenue generation concerns that investors already hold about the company; second, this news may have been released after a separate negative catalyst (earnings miss, insider selling, guidance revision, or liquidity concern) that is not captured in the 48-hour headline window; third, investors may question the deal's genuine monetization potential or suspect the partnership carries hidden dilutive terms. Without additional context on the company's financial health, burn rate, or recent performance, the severe disconnect remains unexplained by the provided headlines alone.

ZONE

CleanCore Solutions IncIndustrials

$0.16−$0.18

-54.3%

NYSE · Mkt cap $34 M

CleanCore announced a $100 million public offering on August 11, which typically causes immediate dilution-driven selloffs in small-cap stocks as existing shareholders face equity dilution and potential downward pricing pressure.

The company announced the pricing of a $100 million public offering on August 11, 2026, following a prior announcement of a proposed offering on August 10. Equity offerings, particularly at this scale relative to what appears to be a micro-cap stock trading at $0.16, create immediate negative pressure through expected shareholder dilution. Investors often sell in advance of or immediately upon pricing announcements because new shares will be issued at or near current market prices, reducing ownership percentages and earnings per share for existing holders. The magnitude of the decline (54.29%) suggests either the offering price was significantly below recent trading levels, market expectations of substantial dilution, or both. Without disclosure of the exact offering price per share, we cannot determine whether additional negative factors beyond standard dilution concerns may have contributed to the severity of the decline.

RETO

Reto Eco-solutions IncBasic Materials

$1.19−$1.24

-51.0%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 51% drop on August 11 cannot be attributed to a disclosed event. The decline likely reflects a market-driven sell-off, technical breakdown, or undisclosed company announcement.

The absence of any headlines in the last 48 hours makes it impossible to tie this dramatic 51% loss to a specific catalyst such as earnings, guidance revision, regulatory action, or business development. For a micro-cap stock like RETO trading near $1.19, large single-day declines can occur due to several structural factors: thin liquidity and wide bid-ask spreads that amplify volatility, stop-loss cascades triggered by technical breakdown below support levels, forced liquidations or margin calls by large holders, rumors or social media pressure not yet reflected in official news, or delayed filing of material information with the SEC. Smaller companies often trade on sentiment and technical patterns rather than fundamental news flow, making them susceptible to sharp reversals without headline triggers. Without access to intraday trading data, SEC filings, or company communications outside of Yahoo Finance RSS, the specific driver remains unknown.

BODI

Beachbody Company IncCommunication Services

$6.22−$4.13

-39.9%

NYSE · Mkt cap $47 M

Beachbody reported strong Q2 earnings with a surprise beat on EPS and positive operating income, but the market focused on the 22.4% revenue decline and may have interpreted guidance or forward outlook as disappointing enough to trigger a sharp 40% sell-off.

The news headlines establish that Beachbody beat earnings expectations (135.71% surprise) and delivered positive EBITDA with a 13.4% margin, marking the fourth consecutive quarter of profitability. Revenue came in near guidance at $49.6 million but declined 22.4% year-over-year. The company is executing a "nutrition-first strategy" and expanding retail presence. However, a 40% single-day drop despite an earnings beat and profitability streak suggests the market either (1) interpreted management's forward guidance or commentary as weaker than expected, (2) found the revenue contraction unsustainable or alarming relative to the turnaround narrative, or (3) reacted to commentary on demand trends, competitive pressure, or subscriber declines that the headlines do not explicitly detail. Without access to the full earnings call transcript or management guidance for Q3 and FY2026, the specific catalyst driving such a severe reaction remains unclear.

CRIS

Curis IncHealthcare

$2.34−$1.33

-36.2%

NASDAQ · Mkt cap $4.2 M

No news headlines were found in the last 48 hours despite CRIS falling 36.20%, making it impossible to identify a specific catalyst from publicly available sources.

Curis Inc experienced a severe single-day loss ranking it among the day's eight biggest losers, yet no news headlines are available to explain the move. For a small-cap biotech stock like CRIS, this type of sharp decline typically correlates with clinical trial setbacks, regulatory disappointment, capital raises at unfavorable terms, or insider selling disclosures. Without access to recent news, the cause could be a delayed earnings report, an announcement released outside the RSS feed window, after-hours guidance, or market-wide biotech sector weakness. It is also possible the decline reflects technical selling or loss of investor confidence tied to earlier news, but this cannot be confirmed from the provided evidence.

CDNL

Cardinal Infrastructure Group Inc. Class A Common StockIndustrials

$38.31−$21.70

-36.2%

NASDAQ · Mkt cap $721 M

Cardinal Infrastructure beat Q2 revenue expectations and raised full-year guidance, but the stock crashed 36% because profitability fell short of management expectations despite the top-line beat, signaling margin pressure and execution concerns.

The headlines reveal a classic earnings paradox. Cardinal delivered record Q2 revenue and substantially increased full-year revenue guidance, which typically triggers rallies. However, the earnings call highlights explicitly note that profitability came in below management expectations. This suggests the company achieved higher sales volumes but at lower margins, possibly due to rising costs, project mix challenges, or integration issues from the Allied Paving Contractors acquisition announced the same day. Investors appear to have punished the stock heavily because strong revenue growth coupled with deteriorating profitability signals operational or cost control problems that may persist, making the higher revenue guidance less valuable. The acquisition itself may also have raised concerns about dilution or integration execution risk, particularly if debt was used for the deal.

GAIA

Gaia IncCommunication Services

$1.23−$0.68

-35.6%

NASDAQ · Mkt cap $38 M

Gaia reported a 5% revenue decline in Q2 2026 that missed estimates by 5.16%, triggering a severe selloff despite beating on earnings per share and management's confidence in future AI-driven growth initiatives.

The stock fell 35.6% immediately following Gaia's Q2 earnings release on August 10-11. The headlines establish that the company missed revenue expectations materially, declining 5% year-over-year and falling 5.16% short of consensus estimates. Although management beat earnings per share by 7.69% and emphasized cost savings and innovative AI features during the earnings call, the top-line miss appears to have dominated investor sentiment. For a media and subscription-based company like Gaia, revenue growth is a critical valuation driver, and a miss of this magnitude can trigger sharp repricing, especially if it signals momentum challenges despite management's longer-term optimism. The disconnect between earnings beat and revenue miss suggests the beat came from expense control rather than operational improvement, which may not reassure growth-focused investors.

GETY

Getty Images Holdings, Inc.Communication Services

$0.29−$0.16

-35.2%

NYSE · Mkt cap $111 M

Getty Images reported Q2 2026 earnings on August 10 with revenue declining 2.5% year-over-year to $229.1 million, missing analyst expectations by 6.49%, and posting a non-GAAP loss of $0.05 per share, triggering a 35% sell-off as weakness in agency and iStock businesses offset enterprise growth.

Getty Images released second-quarter 2026 results on August 10 that disappointed the market on multiple fronts. Revenue of $229.1 million fell short of estimates and declined 2.5% annually, with particular weakness in the agency and iStock business units despite management's focus on balance sheet repair and AI-driven innovation. The company reported a non-GAAP loss per share that significantly missed expectations, with earnings surprises of minus 2,200% noted by one source, indicating a substantial earnings miss. While annual subscription revenue grew to 58.8% of total revenue and the enterprise-focused Getty Images business remained strong, the overall financial performance and guidance implications appear to have driven heavy selling. The magnitude of the stock decline from an already depressed price level of $0.29 suggests investors may have had elevated concerns about the company's trajectory given post-merger integration challenges and revenue headwinds.

UZX

Linkage Global IncConsumer Cyclical

$0.15−$0.08

-35.0%

NASDAQ · Mkt cap $7.8 M

Linkage Global announced it is merely evaluating hotel acoustic wellness technology applications with no partnerships or commercial agreements signed yet, disappointing investors expecting concrete business progress and sending the stock down 35%.

The company released news today that it is exploring potential hotel deployments for its AI-enabled acoustic wellness technology. However, the announcement explicitly states the initiative remains at an evaluation stage with no commercial agreements currently in place. For a micro-cap stock trading at $0.15, investor expectations were likely centered on concrete partnership announcements or signed customer deals that would demonstrate revenue traction. Instead, the market received a vague exploratory statement that amounts to early-stage research with no financial commitment from hospitality partners. This gap between speculative positioning and the absence of binding commercial progress appears to have triggered the sharp 35% sell-off, particularly given UZX's position as a 12th-biggest loser today, suggesting sector-wide or company-specific disappointment rather than isolated technical weakness.

ZVZZT

$25.10−$13.45

-34.9%

SLXN

Biomotion SciencesHealthcare

$1.04−$0.49

-32.1%

NASDAQ · Mkt cap $540 K

No headlines were found in the last 48 hours, so the cause of the 32% drop cannot be confirmed from news sources; the move likely reflects either a significant unreported development, technical selling, or a company-specific catalyst that has not yet been picked up by major news feeds.

Biomotion Sciences experienced a steep 32% single-day decline with no corresponding headlines appearing in the Yahoo Finance RSS feed over the past two days. This disconnect suggests either that the catalyst has not yet reached mainstream financial news aggregators, or that the move is driven by factors other than new public information. For a small-cap biotech or medical device company trading at $1.04, typical catalysts include clinical trial results, regulatory setbacks, capital raises at unfavorable terms, insider selling, short-seller reports, or execution challenges. Given the magnitude of the drop and the lack of news coverage, the most likely scenarios are an earnings miss, a clinical or regulatory setback that has been disclosed but not yet widely indexed, or a significant equity dilution announcement that markets are repricing quickly downward.

KLXE

KLX Energy Services Holdings IncEnergy

$1.55−$0.68

-30.4%

NASDAQ · Mkt cap $35 M

KLX announced a $125 million rights offering on the heels of Q2 earnings; while the company reported strong adjusted EBITDA growth, the equity dilution and leverage-reduction signal likely spooked investors despite positive operational results.

The headlines reveal that KLX reported Q2 2026 results on August 10, with a 68% surge in adjusted EBITDA and a positive earnings surprise of 21.95%, which would normally support the stock. However, the company simultaneously announced a $125 million backstopped rights offering designed to reduce leverage. Rights offerings are typically viewed negatively by existing shareholders because they create immediate dilution and signal financial distress or covenant pressure, even when operational metrics are strong. The stock's 30% drop today suggests the dilution risk and balance sheet concerns outweighed the positive earnings beat in investor sentiment. The timing—announcing both strong results and a capital raise in the same window—is consistent with management trying to repair a weakened balance sheet while operational performance remained solid.

PAL

Proficient Auto Logistics, Inc. Common StockIndustrials

$5.09−$2.15

-29.7%

NASDAQ · Mkt cap $158 M

Proficient Auto Logistics announced Q2 results showing lower revenue and EBITDA year-over-year, unprofitable operations, and a major acquisition funded partly by convertible debt, triggering a sharp 29.7% sell-off likely driven by profitability concerns and dilution fears.

PAL reported second-quarter earnings that missed expectations significantly, with a negative earnings surprise of -100% and only a minimal revenue beat of 0.81%. The company posted lower revenue and adjusted EBITDA compared to the prior year and operated unprofitably in Q2. While management noted sequential operational improvement within the quarter, the announcement of a transformational acquisition of Hansen & Adkins was paired with a $75 million convertible bond offering to fund the deal. Market participants appear to have reacted negatively to the combination of deteriorating profitability metrics, the need for dilutive financing, and uncertainty around integration risks of doubling network size. The acquisition itself may have been viewed as necessary but insufficient to address near-term earnings headwinds.

KIDZ

Classover Holdings, Inc. Class B Common StockConsumer Defensive

$0.29−$0.12

-29.3%

SGLY

Singularity Future Technology Ltd.Industrials

$6.12−$2.46

-28.7%

NASDAQ · Mkt cap $2.7 M

No headlines appeared in the last 48 hours to explain SGLY's 28.67% drop, so the cause remains unclear without additional reporting or company disclosures.

The absence of any news in the provided headlines over the last 48 hours makes it impossible to identify a specific catalyst for the sharp 28.67% decline. For a micro-cap or lower-liquidity stock like Singularity Future Technology, such moves can stem from several sources: a delayed earnings miss or guidance cut released outside of standard trading windows, insider trading activity or Form 4 filings that signal negative sentiment, technical selling driven by chart breaks or margin calls, broader sector rotation away from speculative tech positions, or undisclosed company developments that have not yet been indexed by major news feeds. Without access to SEC filings, company press releases, or verified trading data showing unusual volume or institutional selling, pinpointing the precise cause is not possible from the data at hand.

AREN

The Arena Group Holdings, Inc.Communication Services

$1.58−$0.63

-28.5%

NYSE · Mkt cap $50 M

The Arena Group reported Q2 2026 earnings showing significant drops in revenue and adjusted EBITDA, triggering a 28.51% stock collapse despite management's pivot to AI and acquisition announcements.

On August 10, 2026, The Arena Group (rebranding to Paradium.AI) released Q2 2026 results alongside multiple strategic announcements including the acquisition of InfoSentience, a debt refinance, and launch of Cutter Studios. The earnings headlines explicitly state the company experienced significant declines in both revenue and adjusted EBITDA during the quarter. While management framed these results within a narrative of aggressive repositioning toward AI technology and data-driven content generation, the underlying financial deterioration appears to have overwhelmed investor confidence in the turnaround story. The combination of material earnings misses paired with strategic pivots suggests either operational challenges in the core business or market skepticism that acquisitions and rebranding alone can reverse negative momentum. The timing of the earnings release on August 10 with the stock's 28.51% drop on August 11 directly correlates to this financial disclosure.

MGIH

Millennium Group International Holdings Limited - Ordinary SharesConsumer Cyclical

$1.51−$0.63

-28.4%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the 28.44% drop cannot be directly attributed to a disclosed catalyst; the cause likely involves technical selling, delayed news digestion, or market sentiment shifts.

The absence of any recent headlines makes it impossible to tie the sharp 28.44% decline to a specific corporate event. Millennium Group International is a relatively small-cap NASDAQ stock, and such stocks are prone to volatility from several sources when news is silent: accumulation of negative sentiment from earlier undisclosed developments, algorithmic or margin-driven selling, options expiration effects, or broader sector weakness. Without access to social media, insider trading filings, or afterhours news beyond the Yahoo Finance RSS feed, we cannot identify whether the move reflects a delayed market reaction to old news, a technical breakdown, or an unannounced event that has not yet reached mainstream reporting. The rank as the 20th biggest loser suggests real volume participation, not a glitch, but the mechanism remains opaque.

PYXS

Pyxis Oncology, Inc.Healthcare

$2.81−$1.02

-26.5%

NASDAQ · Mkt cap $214 M

No news headlines were found in the last 48 hours, so the 26.54% drop cannot be directly attributed to a specific announced event; the decline likely reflects either a delayed market reaction to an earlier announcement, a clinical or operational setback, or sector-wide pressure on small-cap biote…

The absence of recent headlines is notable given the magnitude of the decline, which ranks PYXS as the 21st biggest loser of the day. For a clinical-stage or early commercial oncology company, sharp single-day drops of this size are typically triggered by specific catalysts such as negative clinical trial results, FDA action, loss of financing, or management changes. Since no news appears in the last 48 hours, the catalyst may have been released before the snapshot window, embedded in a press release not yet picked up by RSS feeds, or reflect deteriorating investor sentiment tied to sector headwinds affecting small-cap biotech valuations broadly. Another possibility is an earnings or quarterly update that disappointed relative to expectations, or guidance withdrawal. Without confirmed headlines, the exact driver remains speculative.

WAFU

Wah Fu Education Group LtdConsumer Defensive

$1.68−$0.64

-26.5%

NASDAQ · Mkt cap $6.3 M

Wah Fu announced expansion into AI vertical customization projects on August 10, but the stock fell 26.53% the next day, suggesting the market either viewed the initiative as insufficient, questioned execution risk, or reacted to unrelated negative catalyst not captured in available headlines.

The only headline available is a positive business development announcement regarding AI model customization and industrial expansion, released on August 10 after market hours. This type of strategic initiative announcement typically supports or is neutral to stock price, making it an unlikely direct cause of a 26.53% single-day collapse. The sharp drop on August 11 suggests either a negative market reaction to the specific details of the AI announcement (execution concerns, unclear ROI, competitive threat), a separate negative catalyst not reflected in the news provided, or a confluence of factors including sector rotation, short covering reversal, or analyst downgrade that occurred between August 10 and August 11. Without additional earnings data, guidance changes, or macroeconomic context, the true catalyst remains unclear.

XTNT

Xtant Medical Holdings IncHealthcare

$0.33−$0.11

-25.7%

NYSE · Mkt cap $46 M

Xtant Medical dropped 25.74% following Q2 2026 earnings that revealed declining revenue and margins, offsetting management's strategic growth narrative around Dillon integration and new product launches.

The company reported second-quarter results on August 11 showing deteriorating financial performance in a key period. While headlines frame management's commentary as positioning for growth through acquisition integration and market expansion targeting a $7.5 billion opportunity, the underlying earnings data disclosed declining revenue and compressed margins. Markets typically respond negatively to missed or weakened results regardless of forward-looking optimism, particularly in medical technology where investor confidence hinges on demonstrated revenue growth. The 25.74% single-day drop suggests the earnings miss was material enough to override confidence in strategic initiatives. Without access to guidance revisions, specific margin percentage changes, or analyst consensus figures, the precise magnitude of disappointment cannot be quantified, but the severity of the move indicates the results fell meaningfully short of investor expectations.

TTEC

TTEC Holdings IncTechnology

$1.72−$0.59

-25.5%

NASDAQ · Mkt cap $68 M

TTEC crashed 25.54% after missing Q2 earnings and revenue estimates by 87% and 4.3% respectively, with management citing pressure in the Engage segment and now reviewing strategic alternatives for its Digital business.

The earnings miss is severe and unambiguous. TTEC reported an earnings surprise of -86.96%, meaning actual earnings fell dramatically short of analyst expectations for the second quarter ended June 2026. Revenue also missed by 4.33%. The earnings call highlights indicate revenue and profitability declined year-over-year, with specific weakness in the Engage segment. Additionally, management announced it is reviewing strategic alternatives for the TTEC Digital business segment and pursuing cost reduction measures, which investors typically interpret as potential divestitures, restructuring, or other value-destroying actions. The combination of a massive earnings miss, declining profitability, segment pressure, and strategic review triggered a severe sell-off. This is a classic earnings disappointment catalyst with additional uncertainty from the strategic review announcement.

LIF

Life360, Inc. Common StockTechnology

$48.61−$16.34

-25.2%

NASDAQ · Mkt cap $3.6 B

Life360 reported record Q2 revenue growth of 38% and surpassed 100 million monthly active users, but the stock fell 25% due to a soft full-year outlook and a 25% decline in earnings per share despite strong revenue growth.

The earnings announcement on August 10 presents a classic disconnect between top-line growth and bottom-line profitability. Life360 delivered impressive headline metrics: 38% year-over-year revenue growth to $159 million, record user additions of 185 thousand paying circles, and 102.4 million monthly active users. However, the market's sharp negative reaction stems from two factors evident in the headlines. First, earnings per share declined 25% despite revenue growing 38%, indicating significant margin compression or increased expenses that offset revenue gains. Second, the company issued soft guidance for the full year, which signals management's concern about forward growth momentum or profitability trajectory. For a growth-stage platform company like Life360, investors expect operating leverage and expanding margins as the user base scales. The combination of decelerating profitability and cautious forward guidance triggered a substantial valuation reset, positioning the stock as a sell despite absolute user growth achievements.

OPFI

OppFi Inc.Financial Services

$6.58−$2.19

-25.0%

ONVO

Organovo Holdings IncHealthcare

$0.35−$0.12

-24.7%

NASDAQ · Mkt cap $572 K

No news headlines were found in the last 48 hours to explain ONVO's 24.66% single-day drop, so the catalyst remains unclear without additional context.

The absence of recent news makes it impossible to pinpoint a specific cause for this sharp decline. ONVO is a biotech company focused on 3D-printed human tissues, a high-risk, pre-revenue or early-stage sector historically sensitive to clinical trial results, funding announcements, partnership developments, and broader biotech sentiment shifts. Without disclosed headlines, the drop could stem from several categories: a delayed announcement that became public through other channels, negative clinical or regulatory news not yet captured in the RSS feed, a capital raise or dilution announcement, market-wide biotech sector weakness, technical selling, or deteriorating investor sentiment toward the company's technology or business model. Stocks at this price point can be volatile on thin trading volumes, which can amplify intraday moves.

GRNQ

Greenpro Capital CorpIndustrials

$9.26−$2.75

-22.9%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours to explain GRNQ's 22.87% drop, so the cause remains unclear without additional context on company-specific developments or market conditions.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for this sharp decline. GRNQ is a microcap fintech and blockchain-focused company, a sector prone to volatility and sensitive to shifts in investor sentiment around regulatory uncertainty, crypto market conditions, or company-specific operational issues. The magnitude of the drop (nearly 23%) suggests either a material negative development that has not yet propagated to major news outlets, a delayed market reaction to an older announcement, technical selling pressure, or a broader sector rotation out of speculative financial technology stocks. Without confirmed reporting, the cause could range from insider trading activity, guidance disappointment, regulatory concern, or simply reduced liquidity in a thinly traded security triggering a cascade of stop-losses.

SAC.WT

Safeguard Acquisition Corp. WT

$0.47−$0.13

-21.7%

GYGY

Game Your Game, Inc.Technology

$2.39−$0.65

-21.3%

NASDAQ · Mkt cap $25 M

GYGY dropped 21.31% on August 11, 2026, with no news headlines identified in the last 48 hours; the cause is unknown without additional context on company-specific events, market conditions, or rumors.

No recent news headlines were found in the 48-hour window preceding this steep 21% decline, which significantly limits the ability to identify a concrete catalyst. The magnitude of the move suggests either a material negative development that has not yet appeared in major financial news feeds, a sharp reversal in technical momentum, or a company-specific event that may not have been widely disseminated. For a microcap stock like GYGY trading near $2.39, liquidity constraints and low trading volume can amplify intraday price swings, but this does not explain the directional motivation. Possible categories of unstated catalysts could include delayed earnings disappointment, insider selling, analyst downgrade circulation, or sector-wide pressure, though without corroborating headlines or structural data, these remain pure speculation rather than evidence.

EVC

Entravision Communications CorpCommunication Services

$9.23−$2.49

-21.2%

NYSE · Mkt cap $776 M

EVC fell 21% despite reporting strong Q2 revenue and operating profit growth, suggesting investors either feared disappointing forward guidance, margin compression details, or faced a broader sell-off in advertising tech stocks unrelated to the earnings beat itself.

The earnings headlines confirm that Entravision delivered sharply higher Q2 revenue and operating profit, with growth led by its Advertising Technology & Services business. On the surface, this is a positive result. However, a 21% single-day drop despite a beat is unusual and points to one of three possibilities: (1) management provided weak forward guidance or cut full-year expectations during the earnings call, (2) operational metrics such as margins, customer churn, or spending trends disappointed relative to market expectations, or (3) the stock fell victim to a sector-wide or market-wide selloff in advertising technology names that has nothing to do with EVC's own performance. The headlines provided do not include specific guidance, margin data, or management commentary that would clarify which scenario occurred. Without access to the full earnings call transcript or detailed press release, we cannot definitively identify the catalyst.

ELVA

Electrovaya Inc. - Common SharesIndustrials

$7.32−$1.94

-21.0%

NASDAQ · Mkt cap $381 M

Electrovaya fell 21% despite reporting record gross margins and adjusted EBITDA, likely because Q3 revenue and earnings both missed analyst estimates significantly, triggering a sharp selloff despite positive forward guidance and the Amazon deal.

The headlines reveal a classic earnings disappointment story. On August 10th, Electrovaya reported that earnings and revenue missed consensus estimates by 66.67% and 17.62%, respectively. While the company simultaneously announced record quarterly gross margins of 34.9% and record adjusted EBITDA of $3.7 million (up 27% year-over-year), plus a commercially significant Amazon agreement and new product launch (ElvaPulse 1500), these operational wins were eclipsed by the earnings miss. The company also revised its full-year outlook downward citing supply chain delays. Investors appear to have prioritized the near-term earnings shortfall and revised guidance over the longer-term strategic positives, driving the 21% drop. The August 9th analyst upgrade from CA$12.55 to CA$13.99 fair value proved insufficient to counter the post-earnings momentum.

VEEA

Veea Inc.Technology

$0.13−$0.03

-20.7%

NASDAQ · Mkt cap $8.6 M

No news headlines were found in the last 48 hours to explain VEEA's sharp 20.69% decline, so the drop likely stems from technical selling, sector weakness, or undisclosed company developments.

The absence of any news in the last 48 hours makes it difficult to pinpoint a specific catalyst for VEEA's significant one-day loss. For a micro-cap stock trading at $0.13, declines of this magnitude can occur from several sources: broad market selloffs or sector rotation affecting similar companies, technical breakdown below key support levels triggering algorithmic selling, short-term trader liquidations, or delayed announcements not yet captured in the news feed. Without a named catalyst in the available headlines, we cannot isolate which of these factors drove today's move. It is also possible that news exists but has not yet propagated to the Yahoo Finance feed, or that company-specific developments occurred outside of formal announcements.

ONON

On Holding AGConsumer Cyclical

$30.91−$7.90

-20.4%

NYSE · Mkt cap $9.4 B

On Holding reported Q2 revenue below expectations and cut full-year sales growth guidance, particularly due to slowdown in its largest Americas market, triggering a 20% stock plunge on August 11.

On Holding disclosed second-quarter net sales that missed Wall Street estimates and issued full-year 2026 constant-currency sales growth guidance at the lower end of prior ranges. The core problem appears to be a sharp deceleration in the Americas region, where growth slowed to 13% in Q2 from 17% the prior quarter. Multiple headlines note management was tightening wholesale channel control to protect margins, but this operational shift proved insufficient to offset the top-line disappointment. One headline mentions the company raised its full-year gross margin outlook, which is a positive, but the revenue miss and forward guidance reduction dominated investor reaction. The consistent magnitude of the decline across nearly every headline—ranging from 16% to 22% intraday—suggests the market repriced the stock sharply downward on earnings day itself.

IHRT

iHeartMedia IncCommunication Services

$2.94−$0.74

-20.0%

NASDAQ · Mkt cap $481 M

iHeartMedia reported Q2 earnings late on August 10 that beat revenue expectations but posted a massive earnings miss (down 95.24%), likely triggering the 20% stock decline as investors reassessed profitability despite positive revenue growth headlines.

iHeartMedia announced Q2 2026 results on August 10 after market close, showing consolidated revenue of $977 million, up 4.7% and exceeding prior outlook with a modest +0.24% revenue surprise. However, the earnings surprise was dramatically negative at -95.24%, indicating the company posted a significant loss when investors expected profitability. While headlines emphasize positive metrics like Digital Audio Group EBITDA outperforming Multiplatform for the sixth consecutive quarter and a new Disney+ video podcast deal, the massive earnings miss appears to have dominated the market's initial reaction. The stock's 20% drop suggests investors are concerned about underlying profitability and margin pressures despite top-line growth, particularly given the company's capital-intensive business model and competitive pressures in digital audio.

PRPL

Purple Innovation IncConsumer Cyclical

$7.24−$1.81

-20.0%

NASDAQ · Mkt cap $25 M

Purple Innovation reported Q2 earnings on August 10 that missed revenue expectations by 4.06% with sales down 6.5% year-over-year, triggering a 20% stock collapse despite beating earnings per share estimates and raising Q3 guidance.

Purple reported Q2 2026 revenue of $98.27 million, falling short of consensus estimates and declining 6.5% compared to the prior year quarter. While the company delivered an earnings surprise of +24% and highlighted improved adjusted EBITDA and record gross margins, the revenue miss appears to have dominated market sentiment. The headlines note the company is navigating wholesale headwinds, which likely pressures investor confidence in near-term growth prospects despite the raised full-year revenue guidance mentioned in one article. The 20% single-day drop is severe and suggests the revenue shortfall combined with wholesale channel weakness outweighed operational improvements and forward guidance, causing institutional and retail investors to reprice the stock downward substantially.

HUBG

Hub Group IncIndustrials

$37.98−$9.40

-19.8%

NASDAQ · Mkt cap $2.2 B

Hub Group filed a Form 12b-25 notification of late filing with the SEC on August 11, signaling a delay in submitting required financial reports, which triggered the 19.84% stock price decline.

Hub Group's filing of Form 12b-25 is a regulatory red flag that indicates the company cannot meet SEC deadlines for filing its quarterly or annual report. This form is required when a registrant cannot timely submit required periodic reports to the SEC. The market typically interprets such filings negatively because they suggest internal control issues, accounting complications, or operational problems that prevent timely financial disclosure. The company did provide a first half 2026 business update alongside the late filing notification, but the headlines do not detail the content or financial performance of that update. The timing of this announcement on August 11 immediately preceded the 19.84% single-day drop, making the late filing notification the most plausible direct trigger. Prior articles from August 9 and 10 labeled the stock as risky but lacked specific negative catalysts, so the Form 12b-25 represents a material new disclosure event that market participants reacted to sharply.

BYND

Beyond Meat IncConsumer Defensive

$0.42−$0.10

-19.8%

NASDAQ · Mkt cap $242 M

Beyond Meat announced a 1-for-30 reverse stock split on August 11, which mechanically reduces share count and price per share while preserving market cap; the -19.79% drop reflects market negativity toward the restructuring, likely signaling financial distress or shareholder dilution concerns.

The headline confirms Beyond Meat's board approved a 1-for-30 reverse stock split effective today. Reverse splits are mechanically neutral for market capitalization but are typically viewed as negative signals by markets because they are often used by companies facing financial distress, delisting risk, or to reset a stock price that has fallen substantially. A reverse split reduces the number of outstanding shares while increasing the nominal price per share proportionally; however, investor sentiment toward reverse splits is generally poor because they do not address underlying business problems and can precede additional dilutive financing or restructuring. The 19.79% single-day drop suggests the market interpreted this announcement as a red flag about the company's financial health or strategic position, rather than a neutral administrative action.

TGE.WT

The Generation Essentials Group

$0.15−$0.03

-19.1%

NYSE

No news headlines were published in the last 48 hours for TGE.WT, so the 19% drop cannot be attributed to a specific announced event. The decline likely reflects technical selling, market-wide pressure on micro-cap stocks, or untracked news.

The absence of recent headlines makes it impossible to pinpoint a fundamental catalyst for the sharp 19% one-day decline. TGE.WT is a warrant security trading at a very low price point, which typically means high volatility and sensitivity to thin trading volumes. Warrant-based securities are inherently more volatile than common stock and can experience outsized moves on minimal volume shifts or losses in speculative interest. Possible explanations include broad market weakness affecting micro-cap names, deteriorating sentiment toward the underlying company without formal announcement, redemption pressure if the underlying SPAC or trust is underperforming, or simple technical capitulation in a security that lacks institutional liquidity. Without access to intraday volume data, insider trading activity, or non-public rumors, the specific trigger remains opaque.

GCTS

GCT Semiconductor Holding, Inc.Technology

$2.04−$0.44

-17.6%

NYSE · Mkt cap $182 M

GCT Semiconductor's Q2 revenue of $1 million missed expectations and fell 18% year-over-year, driving a sharp sell-off despite 71% sequential growth in 5G chipset shipments during early commercialization.

The headlines establish that GCTS reported Q2 2026 earnings on August 10-11, 2026, with a clear miss on revenue expectations. The company posted $1 million in quarterly revenue, down from $1.2 million in the prior year, representing an 18% decline. While management highlighted strong sequential momentum with 5G chipset shipments surging 71% quarter-over-quarter and emphasized the company is navigating early-stage commercialization with a diversified pipeline, the absolute revenue contraction and apparent net loss widening appear to have overshadowed these positive developments in investor sentiment. The market reaction suggests investors prioritized the year-over-year revenue decline and missed quarterly targets over the early commercialization narrative. This is consistent with how pre-revenue or low-revenue semiconductor companies trading on forward guidance are punished when actual results disappoint, even if underlying business momentum is improving on relative metrics.

WLDS

Wearable Devices LtdTechnology

$2.89−$0.61

-17.4%

NASDAQ · Mkt cap $6.0 M

WLDS dropped 17.43% despite announcing a new U.S. patent grant for biometric authentication technology, suggesting the market either viewed the patent as immaterial, priced in the patent earlier, or was driven by unrelated negative catalysts such as broader sector weakness or company-specific con…

The single headline provided reports a positive development: a continuation patent protecting biometric user authentication for gesture and voice-controlled devices, which the company frames as enabling secure payments and user detection. However, patent grants alone rarely drive sustained stock rallies and may not move the needle for investors focused on revenue, profitability, or near-term product launches. The magnitude of the decline—a 17.43% drop ranking WLDS as the 41st biggest loser of the day—is difficult to reconcile with a routine patent announcement unless the market was anticipating more concrete news (clinical data, partnership, earnings beat, guidance raise). It is possible the patent was already known or priced in, or that negative pressure from sector headwinds, short-selling, or undisclosed company-specific events overwhelmed any positive sentiment from the patent.

ACCS

ACCESS NEWSWIRE INCCommunication Services

$5.37−$1.13

-17.4%

NYSE · Mkt cap $19 M

ACCESS Newswire beat revenue estimates by 1.78% and showed operational progress (94% customer retention, rising ARR per customer to $12,718), but the stock fell 17.39%, likely due to gross margin pressure and elevated sales investment costs that weighed on profitability despite the top-line beat.

The earnings headlines present a mixed picture. ACCESS delivered a revenue beat of 1.78% and met EPS estimates exactly, with positive operational metrics including improved customer retention at 94% and new AI-driven products expanding average purchase values. However, the earnings call highlights explicitly note that gross margin pressure and higher sales investment investments weighed on profitability. This margin compression despite revenue growth often signals to investors that the company is sacrificing near-term profits for growth, or that unit economics are deteriorating. The market's 17% decline suggests investors reacted negatively to the profitability headwinds, viewing them as a significant concern that outweighed the operational improvements. Without forward guidance or commentary on margin trajectory, the severity of this pressure likely drove the sell-off.

ASPCR

A SPAC III Acquisition Corp.

$0.09−$0.02

-17.3%

NASDAQ

No news headlines were found in the last 48 hours, so the 17.27% drop likely reflects typical illiquidity and volatility in a low-priced SPAC stock or a delayed market reaction to an earlier development.

ASPCR is a SPAC (special purpose acquisition company) trading at $0.09, a price point associated with high volatility and low liquidity. No news appeared in the Yahoo Finance RSS feed during the relevant period, which means either no material announcement was made, or coverage was delayed or absent from that particular feed. SPACs in this price range often experience sharp moves on thin volume driven by redemption pressure, failed merger timelines, sponsor activity, or shifts in the underlying merger target's status. Without access to headlines, the most probable categories are technical selling in a low-float security, a delayed reaction to news from before the 48-hour window, or routine SPAC volatility unrelated to identifiable corporate events. The absence of headlines does not rule out a real catalyst; it simply means the evidence is not visible here.

VWAV

VisionWave Holdings, Inc.Industrials

$1.07−$0.22

-16.8%

NASDAQ · Mkt cap $36 M

No news headlines were available in the last 48 hours to explain VisionWave's 16.78% drop, so the cause remains unclear; the decline likely stems from a market-moving event, earnings release, or technical selling not yet reflected in the RSS feed.

VisionWave Holdings experienced a sharp single-day decline of 16.78% to $1.07 on August 11, 2026, ranking it among the day's biggest losers. However, no news headlines were found in the last 48 hours of the Yahoo Finance RSS feed that would directly explain this move. This is a notable gap, as a decline of this magnitude in a micro-cap or small-cap stock typically correlates with a specific catalyst. Possible explanations include an earnings announcement or guidance miss, insider selling or dilution event, a halt or trading restriction, deterioration in a material business contract, or simply a delayed reporting of news to the RSS feed. Without corroborating headlines or knowledge of the company's fundamental position, we cannot isolate the proximate cause from technical selling, sector rotation, or exogenous market pressure.

TOPP

Toppoint Holdings Inc.Industrials

$0.24−$0.05

-16.7%

NYSE · Mkt cap $5.3 M

No news was reported in the last 48 hours to explain the 16.70% decline in TOPP. The drop likely reflects broad market sentiment, technical selling, or undisclosed company developments not yet captured in headlines.

The absence of any Yahoo Finance headlines in the past 48 hours for a stock experiencing a top-50 daily loss is notable and leaves the precise catalyst unclear. For a micro-cap equity like TOPP trading at $0.24, declines of this magnitude can be driven by several categories: technical breakdown or stop-loss cascades, delayed or private company announcements not yet syndicated to major news feeds, sector-wide headwinds, short covering reversals, or liquidity-related forced selling. Without access to company filings, earnings calendars, or real-time trading volume data, attributing the move to a specific operational or financial event is not possible. The lack of news coverage also suggests either that the trigger is still emerging or that it occurred through channels outside mainstream financial media.

WVE

WaVe Life Sciences LtdHealthcare

$5.05−$1.01

-16.7%

NASDAQ · Mkt cap $926 M

WVE fell 16.68% on August 11, 2026, but no news headlines were available in the prior 48 hours to explain the move, suggesting the catalyst either occurred before the snapshot window or was driven by market technicals or untracked developments.

No recent news headlines were retrieved for WaVe Life Sciences in the last 48 hours, so the specific trigger for the 16.68% decline cannot be directly identified from the provided evidence. WaVe is a small-cap biotechnology company focused on genetic medicines and rare disease treatments, sectors highly sensitive to clinical trial outcomes, regulatory decisions, funding announcements, and analyst revisions. A drop of this magnitude in a biotech stock typically correlates with adverse clinical data, FDA feedback, capital raises at unfavorable terms, or significant analyst downgrades. Without headlines, the cause remains speculative, though biotech volatility driven by undisclosed trial readouts or insider transactions is not uncommon. The lack of news coverage itself may indicate the catalyst was internal or market-driven rather than a major announced event.

TVAIR

Thayer Ventures Acquisition Corporation II Rights

$0.13−$0.02

-16.3%

NASDAQ

No news headlines appeared in the last 48 hours, but TVAIR is a SPAC rights unit with inherent volatility and declining or near-worthless underlying value typical of post-merger or failed SPAC vehicles, making a 16% drop unsurprising absent any positive catalyst.

Zero news headlines were published in the 48 hours preceding this move, so no specific corporate event can be identified as the driver. TVAIR is a rights offering tied to Thayer Ventures Acquisition Corporation II, a SPAC structure. Rights units in mature or failed SPACs typically trade at or near zero intrinsic value once the merger window closes or no deal materializes, and they are highly sensitive to any shift in sponsor liquidity, regulatory changes, or broader SPAC sentiment. The stock trades at $0.13, suggesting it has minimal economic value. A 16% drop from such a low base could reflect either a technical decline or response to delayed news not yet captured in this RSS feed, but the most likely category is deteriorating confidence in the underlying warrant or merger vehicle itself, which is typical for SPACs in their terminal phases.

NUTX

Nutex Health, Inc.Healthcare

$166.35−$31.70

-16.0%

NASDAQ · Mkt cap $1.4 B

No news headlines were available in the last 48 hours, so the cause of the 16% drop cannot be directly attributed to reported events. This move likely stems from earnings results, guidance, an insider transaction, or broader sector rotation not yet captured in the provided news sources.

Nutex Health experienced a substantial single-day loss of 16.01%, placing it among the day's largest decliners, yet no recent news headlines were available to explain the move. This disconnect suggests either that the catalyst has not yet been widely reported through mainstream financial news feeds, or that the move was driven by intraday trading activity, technical factors, or company-specific developments that have not yet reached public disclosure. For healthcare and biotech-adjacent stocks like Nutex, typical catalysts for sharp moves include clinical trial results, regulatory decisions, earnings surprises, insider selling, financing announcements, or changes to guidance. Without supporting headlines, the specific trigger remains unknown, though the magnitude suggests a material event rather than mere technical selling or sector-wide weakness.

PETZ

TDH Holdings IncReal Estate

$1.37−$0.28

-16.0%

NASDAQ · Mkt cap $12 M

PETZ fell 16% on August 11, 2026, but no news headlines were available in the prior 48 hours to explain the move directly, leaving the cause unclear.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for PETZ's 16% single-day decline. Given that TDH Holdings operates in the pet retail and services space, plausible drivers could include sector-wide pressure (e.g., consumer spending weakness in discretionary categories), company-specific operational concerns not yet reported by major outlets, short covering or algorithmic selling following a prior rally, or broader market rotation out of small-cap NASDAQ stocks. Penny-stock-range equities like PETZ are also vulnerable to technical capitulation or low-volume panic selling that may not correspond to fundamental news. Without concurrent headlines or earnings announcements visible in the search results, we cannot rule out delayed reporting, internal developments, or pure technical factors.

NOTE

FiscalNote Holdings, Inc.Technology

$0.07−$0.01

-15.9%

NYSE · Mkt cap $2.0 M

FiscalNote reported Q2 2026 earnings that missed revenue estimates and delivered a net loss, combined with lowered full-year guidance, triggering the 15.88% stock price decline.

FiscalNote released Q2 2026 earnings on August 10 showing a revenue miss of 0.88% versus estimates and a net loss with an earnings surprise of negative 11.63%. Most critically, the company lowered its full-year guidance despite management highlighting improved net revenue retention and AI-driven growth initiatives as stabilization signals. This mixed message—operational improvements offset by both current-quarter misses and reduced forward expectations—typically pressures stock valuations, particularly for growth-dependent software or data firms. The revenue decline of 16% year-over-year reinforces concerns about core business contraction, even if management framed certain metrics positively.